ghk-cu peptide oral bioavailability What is the of the GHK‑Cu (glycyl‑L‑histidyl‑L‑lysine copper) peptide? Frontiers | Exploring the beneficial
Description
Safety Profile and Concerns The short systemic half-life of IGF-1 DES theoretically reduces some concerns associated with chronic IGF-1 elevation, particularly cancer risk from sustained systemic receptor activation
But other parts of society followed its lead
The most common side effects are injection site inflammation or swelling
Leske MC (2009) Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings
10.1038/mi.2010.5 63
